PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1320974

Coronary vasospasm induced by subcutaneous sumatriptan.

F Willett·N Curzen·J Adams·M Armitage
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Coronary VasospasmHumansIndolesInjections, SubcutaneousMaleMiddle AgedSulfonamidesSumatriptanCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Willett, N Curzen, J Adams, M Armitage. 1992-05-30. Coronary vasospasm induced by subcutaneous sumatriptan.. https://doi.org/10.1136/bmj.304.6839.1415

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

The mystery of coronary artery spasm.

Coronary artery spasm is an important cause of chest pain and myocardial ischaemia. It can be defined as an exaggerated contractile response of epicardial coronary artery smooth muscle to various stimuli but the underlying mechanism is not well understood. Recent studies have shown that the loss of endothelial vasodilatory function in conjunction with an increase in vascular smooth muscle constrictor sensitivity to calcium are the likely predisposing conditions for coronary spasm. This review highlights current understanding of the pathophysiology, predisposing factors, diagnostic and therapeutic approaches for coronary spasm.

Coronary Vasospasm↗
PubMed2006

Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud's phenomenon.

We present the case of a patient with severe dyspnea and Raynaud's phenomenon. We could clarify, using invasive techniques including left ventricular conductance catheterization and coronary ergonovine provocation, that isolated diastolic dysfunction induced by coronary vasospasm were responsible for the symptoms. Systolic function was not affected. Short-term infusions with the prostacyclin analogue iloprost, known to act as a disease-modifying agent in patients suffering from Raynaud's phenomenon, led to an improvement of cardiac function. Thus, episodes of dyspnea in patients with Raynaud's phenomenon might be also interpreted as a coronary ischemia equivalent, which may belong to a visceral form of Raynaud's phenomenon and which are sensitive to iloprost infusions.

Coronary Vasospasm↗